Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index; 16 of the 54 sources its claims cite were checked for support.
Abstract
Euglycemic hyperinsulinemia evokes both sympathetic activation and vasodilation in skeletal muscle, but the mechanism remains unknown. To determine whether insulin per se or insulin-induced stimulation of carbohydrate metabolism is the main excitatory stimulus, we performed, in six healthy lean subjects, simultaneous microneurographic recordings of muscle sympathetic nerve activity, plethysmographic measurements of calf blood flow, and calorimetric determinations of carbohydrate oxidation rate. Measurements were made during 2 h of: (a) insulin/glucose infusion (hyperinsulinemic [6 pmol/kg per min] euglycemic clamp), (b) exogenous glucose infusion at a rate matched to that attained during protocol a, and (c) exogenous fructose infusion at the same rate as for glucose infusion in protocol b. For a comparable rise in carbohydrate oxidation, insulin/glucose infusion that resulted in twofold greater increases in plasma insulin concentrations than did glucose infusion alone, evoked twofold greater increases in both muscle sympathetic nerve activity and calf blood flow. Fructose infusion, which increased carbohydrate oxidation comparably, but had only a minor effect on insulinemia, did not stimulate either muscle sympathetic nerve activity or calf blood flow. These observations suggest that in humans hyperinsulinemia per se, rather than insulin-induced stimulation of carbohydrate metabolism, is the main mechanism that triggers both sympathetic activation and vasodilation in skeletal muscle.
Overview
CoChat Summary
TL;DR
In healthy lean humans, euglycemic hyperinsulinemia increased muscle sympathetic nerve activity (MSNA) and calf blood flow more than glucose infusion alone despite comparable carbohydrate oxidation, while fructose infusion increased carbohydrate oxidation without stimulating MSNA or calf blood flow. The authors conclude that hyperinsulinemia per se, rather than insulin-induced carbohydrate metabolism, is the main trigger for sympathetic activation and skeletal-muscle vasodilation.
Key findings
- During 2-h insulin/glucose infusion, plasma insulin rose to 376.2±30.0 pmol/liter and increased MSNA burst frequency by 93±18%, calf blood flow by 47±14%, and decreased calf vascular resistance by 19±4%.
- Glucose infusion alone produced comparable carbohydrate oxidation but a smaller insulin rise (282.6±19.8 pmol/liter) and about half the responses: MSNA burst frequency increased 54±10% and calf blood flow 20±6%.
- Fructose infusion increased carbohydrate oxidation even more than insulin/glucose or glucose infusion (23±2 vs 21±1 and 20±1 μmol/kg per min at 90–120 min) but caused only a minor insulin rise (37.2±1.9 to 57.0±2.7 pmol/liter) and had no effect on MSNA, calf blood flow, or calf vascular resistance.
- MSNA and calf blood flow rose significantly at 45 min during insulin/glucose infusion but only at 90 min during glucose infusion; during fructose infusion, glucose oxidation increased by 22±7%.
Methods
- Six lean, healthy subjects (weight 70.8±4.3 kg, BMI 21.8±0.8 kg/m², age 28±4 yr) underwent 2-h protocols: hyperinsulinemic euglycemic clamp (insulin 6 pmol/kg per min), exogenous glucose infusion matched to the clamp, and fructose infusion matched to glucose; five of six subjects completed fructose infusion.
- Simultaneous measurements included microneurographic MSNA recordings from the peroneal nerve, venous occlusion plethysmography for calf blood flow, indirect calorimetry for carbohydrate oxidation, and plasma hormone/substrate assays.
- A fourth protocol in six lean healthy male subjects (age 30±4 yr, BMI 22.9±0.6 kg/m²) used [U-¹³C]glucose infusion and breath ¹³CO₂/plasma [¹³C]glucose enrichment to measure glucose oxidation during fructose infusion.
- Statistical analysis used repeated-measures ANOVA, paired t tests with Bonferroni adjustment, and least-squares correlations; P<0.05 was significant.
Limitations
- The paper states that indirect calorimetry cannot differentiate glucose from fructose oxidation, that nonoxidative glucose disposal calculations were not performed during fructose infusion because endogenous glucose production was not measured and is not suppressed, and that total carbohydrate uptake may have been slightly higher during fructose infusion.
- The paper states that the experiments do not elucidate the underlying mechanisms of insulin-induced sympathetic activation and vasodilation, and that MSNA recordings were targeted specifically at skeletal muscle, so fructose-induced sympathetic outflow to other tissues such as liver cannot be excluded.
- Evident from the text: the main protocols included only six lean healthy subjects (five for fructose), limiting generalizability; the fourth protocol included only male subjects, and the study did not measure interstitial insulin directly.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
11 Valid · 0 Not valid · 16 Not checked · 51 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“First, there is increasing evidence that stimulation of blood flow to insulin-sensitive tissues during insulin/glucose and glucose infusion may be an important determinant of the rate of in vivo glucose uptake (10, 11, 38).”
What the sources say
- Not matchedcites [10] 10. Laakso, M., S. V. Edelman, J. M. Olefsky, G. Brechtel, P. Wallace, and A. D. Baron. 1990. Kinetics of in vivo muscle insulin-mediated glucose uptake in human obesity. Diabetes. 39:965-974.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Partly supportedcites [11] 11. Laakso, M., S. V. Edelman, G. Brechtel, and A. D. Baron. 1990. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J. Clin. Invest. 85:1844–1852. sourceExperimental — accuracy not yet measured
The Discussion (page not provided) says increased blood flow is closely linked to glucose uptake and may contribute particularly after two hours of hyperinsulinemia. The Protocol describes insulin infusion with glucose clamped at euglycemia, but the paper does not establish the same point for glucose infusion without insulin. Its findings also concern skeletal muscle rather than insulin-sensitive tissues generally. (LLM, conf=0.85)
- Not matchedcites [38] 38. Edelman, S. V., M. Laakso, P. Wallace, G. Brechtel, J. M. Olefsky, and A. D. Baron. 1990. Kinetics of insulin-mediated and non-insulin-mediated glucose uptake in humans. Diabetes. 39:955–964.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“as recent evidence indicates that insulin resistance is associated with attenuated hyperinsulinemia-induced vasodilation in skeletal muscle (10, 11).”
What the sources say
- Not matchedcites [10] 10. Laakso, M., S. V. Edelman, J. M. Olefsky, G. Brechtel, P. Wallace, and A. D. Baron. 1990. Kinetics of in vivo muscle insulin-mediated glucose uptake in human obesity. Diabetes. 39:965-974.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Supportedcites [11] 11. Laakso, M., S. V. Edelman, G. Brechtel, and A. D. Baron. 1990. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J. Clin. Invest. 85:1844–1852. source
The Discussion reports that insulin’s effect on skeletal-muscle blood flow is impaired in obese men and that this defect could be associated with in vivo insulin resistance. Its summary also describes a right-shifted blood-flow response to insulin in obese versus lean subjects. The finding is established for the men studied; extension to other insulin-resistant states is presented as a possibility. (LLM, conf=0.91)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, the conclusions of one study were based upon the absence of a detectable effect of glucose infusion on plasma norepinephrine levels (5, 26), a relatively insensitive index of sympathetic discharge (34–36).”
What the sources say
- Partly supportedcites [5] 5. Berne, C., J. Fagius, and F. Niklasson. 1989. Sympathetic response to oral carbohydrate administration. J. Clin. Invest. 84:1403-1409. sourceExperimental — accuracy not yet measured
The Sympathetic activity results report minor or no plasma norepinephrine change after intravenous glucose. But the Discussion bases its conclusion that intravenous glucose did not increase sympathetic activity on direct microelectrode recordings of muscle sympathetic activity, using the norepinephrine results as corroboration—not as the sole basis for the conclusion. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [26] 26. Rowe, J. W., J. B. Young. K. L. Minaker, A. L. Stevens, J. Pallota, and L. Landsberg. 1981. Effects of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 30:219–225. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Second, a balance between insulin's opposing sympathoexcitatory pressor and vasodilatory depressor effects may offer a potential explanation for the present, and earlier (6, 7, 26) observations, that in lean healthy subjects acute hyperinsulinemia at high physiologic concentrations does not raise arterial pressure.”
What the sources say
- Partly supportedcites [6] 6. Anderson, E. A., R. P. Hoffman, T. W. Balon, C. A. Sinkey, and A. L. Mark. 1991. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest. 87:2246–2252. sourceExperimental — accuracy not yet measured
The Discussion says that sympathetic pressor and vasodilatory depressor actions appear relatively balanced during acute insulin increases in the physiologic postprandial range, so arterial pressure does not rise. The Subjects section describes healthy males, but their BMI ranged from 21 to 32; the paper does not establish the finding specifically for lean subjects. (LLM, conf=0.82)
- Supportedcites [7] 7. Berne, C., J. Fagius, T. Pollare, and P. Hjemdahl. 1992. The sympathetic response to euglycaemic hyperinsulinaemia: evidence from microelectrode nerve recordings in healthy subjects. Diabetologia. 35:873–879. source
In the Discussion (page not available in our copy), the authors report that insulin increased muscle sympathetic activity at a high physiological concentration and suggest that this response helps maintain blood pressure despite insulin’s vasodilatory effects. The Abstract reports that blood pressure was not notably affected in the healthy subjects studied. This supports the proposed balance as a possible explanation, rather than an established mechanism. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [26] 26. Rowe, J. W., J. B. Young. K. L. Minaker, A. L. Stevens, J. Pallota, and L. Landsberg. 1981. Effects of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 30:219–225. source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During fructose infusion, plasma glucose concentrations remained stable, whereas plasma fructose concentrations rose from undetectable levels to 2.0±0.2 mmol/liter by the end of the first hour of infusion, and remained unchanged thereafter (Table I).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
47 more claims
Create a free account to see all 78 claims and to verify the 5 references still open.
- Probably not a substantial claim. 14
- It may state two separate claims as one. 13
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In our laboratory, the intraobserver and interobserver coefficients of variation of the mean in identifying bursts are < 6% and < 9%, respectively (14).”
From Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. (1994) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“First, MS components such as visceral obesity, peripheral insulin resistance, and reactive hyperinsulinemia have been found to result in sympathetic hyperactivity.[5][6][7]”
From Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension (2004) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In lean subjects, sympathetic activation evoked by acute elevation of plasma insulin to high physiological concentrations does not raise blood pressure (12–14)”
From Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. (1994) · cites this paper as [14]
The cited source says what the claim attributes to it.
In the citing paper
“In lean healthy subjects, insulin-induced stimulation of muscle blood flow consistently is accompanied by a marked stimulation of sympathetic neural outflow to the same vascular bed (12-14).”
From Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. (1994) · cites this paper as [14]
In the citing paper
“Sympathetic activation has already been associated with many of the individual components of the MS, such as visceral obesity, 5 insulinemia, 6 EHT, [1][2][3][4] and type 2 diabetes.7”
From Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension (2004) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Nonoxidative glucose disposal (pmol/kg per min) | - | 21±4 | 22±8 | - | 6±1t”
Reported 6 · recomputed 12
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Results · p. 3
“had no effect on MSNA, calf blood flow, or calf vascular resistance”
§ Analytical methods · p. 3
“| Calf vascular resistance (Units) | 43.3±1.3 | 34.3±1.6* | 32.8±2.0* | 45.6±2.2 | 42.9±2.7* | 40.5±3.2* | 49.7±5.3 | 49.0±5.7t | 45.7±5.2* |”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Coated Charcoal Immunoassay of Insulin
HERBERT, V., LAU, K.-S., GOTTLIEB, C. W., & BLEICHER, S. J. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1375 · Cited by 2,968
Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves
Vallbo, A. B., Hagbarth, K. E., Torebjork, H. E., & Wallin, B. G. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.4.919 · Cited by 1,507
Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.
Schuler, G., Hambrecht, R., Schlierf, G., Niebauer, J., Hauer, K., Neumann, J., Hoberg, E., Drinkmann, A., Bacher, F., & Grunze, M. (1992) · Circulation · doi:10.1161/01.cir.86.1.1 · Cited by 1,340
Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal Man
Rowe, J. W., Young, J. B., Minaker, K. L., Stevens, A. L., Pallotta, J., & Landsberg, L. (1981) · Diabetes · doi:10.2337/diab.30.3.219 · Cited by 1,143
Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.
Anderson, E. A., Hoffman, R. P., Balon, T. W., Sinkey, C. A., & Mark, A. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115260 · Cited by 1,075
Hawk’s Physiological Chemistry
Prosky, L. (1966) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/49.2.477 · Cited by 1,047
Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114644 · Cited by 930
Parati, G., Casadei, R., Groppelli, A., Di Rienzo, M., & Mancia, G. (1989) · Hypertension · doi:10.1161/01.hyp.13.6.647 · Cited by 899
Hawk's physiological chemistry
HAWK, P. B., & Oser, B. L. (1965) · Medical Entomology and Zoology · Cited by 871
Cited by
Items 101–200 of 323
Hoffman, R. P., Hausberg, M., Sinkey, C. A., & Anderson, E. A. (1999) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(98)00019-1 · Cited by 58
Sartori, C. S., Trueb, L., NICOD, P. H., & Scherrer, U. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.586 · Cited by 54
Self-citationInsulin Resistance, Arterial Stiffness and Wave Reflection
Yki‐Järvinen, H., & Westerbacka, J. (2006) · KARGER eBooks · doi:10.1159/000096746 · Cited by 64
A non- invasive assessment of hepatic glycogen kinetics and post- absorptive gluconeogenesis in man
Gay, L. J., Schneiter, P., Schutz, Y., Vetta, V. D., Jéquier, E., & Tappy, L. (1994) · Diabetologia · doi:10.1007/s001250050141 · Cited by 55
“Fasting plasma 13C glucose enrichment was determined in nine subjects as described [19].”
BackgroundMethodSelf-citationAdenosine Actions are Preserved in Corpus Cavernosum from Obese and Type II Diabetic db/db Mouse
Carneiro, F. S., Giachini, F. R. C., Lima, V. V., Carneiro, Z. N., Leite, R., Inscho, E. W., Tostes, R. C., & Webb, R. C. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00752.x · Cited by 53
“On the other hand, hyperinsulinemia itself increases resting sympathetic output [27-32].”
BackgroundVasodilator Response to Systemic But Not to Local Hyperinsulinemia in the Human Forearm
Cardillo, C., Kilcoyne, C. M., Nambi, S., Cannon, R. O., Quon, M. J., & Panza, J. A. (1998) · Hypertension · doi:10.1161/01.hyp.32.4.740 · Cited by 51
Ganguly, A., Sharma, K., & Majumder, K. (2019) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2019.04.001 · Cited by 57
Anteroventral third ventricle lesions abolish lumbar sympathetic responses to insulin.
Muntzel, M., Beltz, T., Mark, A. L., & Johnson, A. K. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.1059 · Cited by 48
Rosiglitazone effects on blood pressure and metabolic parameters in nondipper diabetic patients
Negro, R., Mangieri, T., Dazzi, D., Pezzarossa, A., & Hassan, H. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.02.012 · Cited by 49
Insulin blunts sympathetic vasoconstriction through the alpha 2-adrenergic pathway in humans.
Lembo, G., Iaccarino, G., Rendina, V., Volpe, M., & Trimarco, B. (1994) · Hypertension · doi:10.1161/01.hyp.24.4.429 · Cited by 52
Effects of insulin on the cardiac autonomic nervous system in insulin-resistant states
Paolisso, G., Manzella, D., Rizzo, M. R., et al. (2000) · Clinical Science · doi:10.1042/cs0980129 · Cited by 48
Cardiovascular Benefits of Exogenous Insulin
Chaudhuri, A., Dandona, P., & Fonseca, V. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1112 · Cited by 47
Update on adipose tissue blood flow regulation
Sotorník, R., Brassard, P., Martin, E., Yale, P., Carpentier, A. C., & Ardilouze, J. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00351.2011 · Cited by 56
Barrett, E. J., & Rattigan, S. (2012) · Diabetes · doi:10.2337/db12-0271 · Cited by 48
“While these observations of insulin’s effect of increasing total limb blood flow were confirmed by a number of laboratories (47,48), concerns were raised and controversy ensued around both the reported need for prolonged, relatively high steady-state insulin concentrations to provoke insulin’s vascular action relative…”
BackgroundMicroneurography and sympathetic nerve activity: a decade-by-decade journey across 50 years
Carter, J. R. (2019) · Journal of Neurophysiology · doi:10.1152/jn.00570.2018 · Cited by 49
“These findings by Anderson et al. (1991a) have since been supported by other laboratories (Vollenweider et al. 1993; Young et al. 2010), and it is the second most cited microneurography article to date.”
BackgroundResultHyperglycaemia modifies the reaction of microvessels to insulin in rat skeletal muscle
Renaudin, C., Michoud, E., Rapin, J. R., Lagarde, M., & Wiernsperger, N. F. (1998) · Diabetologia · doi:10.1007/s001250050862 · Cited by 48
Lepori, M., Sartori, C. S., Trueb, L., Owlya, R., NICOD, P. H., & Scherrer, U. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816040-00013 · Cited by 51
Self-citationTsioufis, C. P., Dimitriadis, K. S., Kasiakogias, A., Kalos, T., Liatakis, I., Koutra, E., Nikolopoulou, L., Kordalis, A., Ella, R. O., Lau, E., et al. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001262 · Cited by 47
Effects of insulin resistance on endothelial function: possible mechanisms and clinical implications
Tousoulis, D., Tsarpalis, K., Cokkinos, D. V., & Stefanadis, C. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00818.x · Cited by 49
Adipokines: Novel Players in Resistant Hypertension
de Faria, A. P., Modolo, R., Fontana, V., & Moreno, H. (2014) · Journal of Clinical Hypertension · doi:10.1111/jch.12399 · Cited by 44
“The SNS activation in obesity has been associated with insulin resistance, thus suggesting that hyperinsulinemia can trigger sympathetic nerve activity.(10) It has been”
BackgroundSanturé, M., Pǐtre, M., Marette, A., Deshaies, Y., Lemieux, C., Larivière, R., Nadeau, A., & Bachelard, H. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704864 · Cited by 46
“The vasodilating action of insulin has been con®rmed by several groups over a range of physiological insulin concentrations and by using di erent techniques (Anderson et al., 1991; Vollenweider et al., 1993; Pitre et al., 1996).”
MethodInsulin resistance in type I diabetes mellitus: a major role for reduced glucose extraction
Mäkimattila, S., Virkamäki, A., Malmström, R., Utriainen, T., & Yki‐Järvinen, H. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.2.8636292 · Cited by 52
Bergholm, R., Westerbacka, J., Vehkavaara, S., Seppälä‐Lindroos, A., Goto, T., & Yki-Järvinen, H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7307 · Cited by 49
“Inhibition of glucose uptake and oxidation by lipid infusion (31) or fructose ( 26 ) does not interfere with insulin stimulation of sympathetic nervous system activity.”
BackgroundN'Guyen, J. M., Magnan, C., Laury, M. C., Thibault, C., Leveteau, J., Gilbert, M., Pénicaud, L., & Ktorza, A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117483 · Cited by 44
Is the insulin resistance syndrome the price to be paid to achieve body weight stability?
Tremblay, A., Boulé, N. G., Doucet, É., & Woods, S. C. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803019 · Cited by 47
Nestler, J. E., & Kahwash, Z. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117487 · Cited by 43
Basolo, A., Burkholder, J., Osgood, K., Graham, A., Bundrick, S., Frankl, J., Piaggi, P., Thearle, M. S., & Krakoff, J. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.017 · Cited by 43
“During GLP-1 infusion increase in EE may have been caused by GLP-1-induced hyperinsulinemia due to sympathetic activation and/or glucose utilization due to activation of thermic response [10, 11].”
BackgroundAsmar, A., Simonsen, L., Asmar, M., Madsbad, S., Holst, J. J., Frandsen, E., Moro, C., Sorensen, C. M., Jonassen, T., & Bülow, J. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00518.2015 · Cited by 41
Glucagon‐like peptide‐1 elicits vasodilation in adipose tissue and skeletal muscle in healthy men
Asmar, A., Asmar, M., Simonsen, L., Madsbad, S., Holst, J. J., Hartmann, B., Sorensen, C. M., & Bülow, J. (2017) · Physiological Reports · doi:10.14814/phy2.13073 · Cited by 41
“Hyperinsulinemia > 400 pmol/L has in previous studies been shown to elicit increase in central sympathetic activity (Rowe et al. 1981; Vollenweider et al. 1993; Scherrer and Sartori 1997; Tack et al. 1998; Paolisso et al. 1999).”
BackgroundYoung, J. B., Weiss, J., & Boufath, N. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1271 · Cited by 45
Effects of different insulin infusion rates on heart rate variability in lean and obese subjects
Paolisso, G., Manzella, D., Tagliamonte, M. R., Rizzo, M. R., Gambardella, A., & Varricchio, M. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90176-2 · Cited by 44
Obesity Affects Myocardial Vasoreactivity and Coronary Flow Response to Insulin
Sundell, J., Laine, H., Luotolahti, M., Kalliokoski, K., Raitakari, O., Nuutila, P., & Knuuti, J. (2002) · Obesity Research · doi:10.1038/oby.2002.84 · Cited by 40
Thermogenesis induced by a high-carbohydrate meal in fasted lean and overweight young men:
Marques-Lopes, I., Forga, L., & Martínez, J. A. (2002) · Nutrition · doi:10.1016/s0899-9007(02)00950-4 · Cited by 41
Autonomic Dysfunction in Diabetes: a Consequence of Cardiovascular Damage
Lefrandt, J. D., Smit, A. J., Zeebregts, C. J., Gans, R. O. B., & Hoogenberg, K. (2010) · Current Diabetes Reviews · doi:10.2174/157339910793499128 · Cited by 40
Rosset, R., Surowska, A., & Tappy, L. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0652-7 · Cited by 42
Self-citationMultiple mechanisms involved in obesity-induced hypertension
Antic, V., Dulloo, A. G., & Montani, J. (2003) · Heart Lung and Circulation · doi:10.1046/j.1444-2892.2003.00200.x · Cited by 48
Verbeek, E., Oliver, M. H., Waas, J. R., McLeay, L. M., Blache, D., & Matthews, L. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037315 · Cited by 45
“These effects are most likely mediated by the sympathetic nervous-adrenomedullary systems and result in the facilitation of muscle glucose uptake [54].”
BackgroundSympathetic nervous system response to intake
Welle, S. L. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.5.1118s · Cited by 40
Orthostatic function after renal sympathetic denervation in patients with resistant hypertension
Lenski, M., Mahfoud, F., Razouk, A., Ukena, C., Lenski, D., Barth, C., Linz, D., Laufs, U., Kindermann, I., & Böhm, M. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.10.017 · Cited by 36
“In patients with resistant hypertension chronic activation of the sympathetic nervous system has been associated with the components of the metabolic syndrome, such as hyperinsulinemia, diabetes and obesity [31,32].”
BackgroundMaciel, M. G., Beserra, B. T. S., Oliveira, F. C. B., Ribeiro, C. M., Coêlho, M. S., Neves, F. D. A. R., & Amato, A. A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.05.034 · Cited by 39
Effect of salt-loading on blood pressure, insulin sensitivity and limb blood flow in normal subjects
FOO, M., DENVER, A. E., COPPACK, S. W., & YUDKIN, J. S. (1998) · Clinical Science · doi:10.1042/cs0950157 · Cited by 36
Magnan, C., Cruciani‐Guglielmacci, C., Clément, L., Adnot, P., Vincent, M., Kergoat, M., Girard, A., Elghozi, J., Velho, G., Beressi, N., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7958 · Cited by 39
Khatun, S., Kanayama, N., Belayet, H. M., Masui, M., Sugimura, M., Kobayashi, T., & Terao, T. (1999) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(99)00050-0 · Cited by 39
Body fat and sympathetic nerve activity
Scherrer, U., Owlya, R., & Leport, M. (1996) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00120490 · Cited by 39
“In lean humans, acute elevation of plasma insulin concentrations to high physiological levels also consistently has been shown to stimulate sympathetic nerve activity as assessed both by measurements of plasma catecholamines [9-14], and, more recently, by direct microneurographic recordings of sympathetic nerve action…”
BackgroundMethodInfluentialSelf-citationMalin, S. K., Liu, Z., Barrett, E. J., & WELTMAN, A. L. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9352-5 · Cited by 39
Health aspects of various digestible carbohydrates
Blaak, E. E., & Saris, W. H. M. (1995) · Nutrition Research · doi:10.1016/0271-5317(95)02027-s · Cited by 37
Tappy, L., Egli, L., Lecoultre, V., & Schneider, P. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-54 · Cited by 34
“Muscle sympathetic nerve activity, which is increased in response to glucose, was however not stimulated by fructose [59].”
BackgroundSelf-citationSoares, R. N., Reimer, R. A., & Murias, J. M. (2017) · Microvascular Research · doi:10.1016/j.mvr.2017.01.003 · Cited by 36
Effects of insulin on regional blood flow and glucose uptake in Wistar and Sprague-Dawley rats
Gaudreault, N., Santuré, M., Pǐtre, M., Nadeau, A., Marette, A., & Bachelard, H. (2001) · Metabolism · doi:10.1053/meta.2001.18569 · Cited by 33
Mechanisms of Adverse Cardiometabolic Consequences of Obesity
Diaz-Melean, C. M., Somers, V. K., Rodríguez-Escudero, J. P., Singh, P., Sochor, O., Llano, E. M., & López-Jiménez, F. A. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0364-2 · Cited by 42
“Throughout the history of obesity research, multiple mechanisms have been proposed to explain the activation of the sympathetic nervous system (SNS) in obesity, including hyperinsulinemia [14], OSA [15], high plasma leptin levels [16], and activation of the renin–angiotensin system.”
BackgroundInsulin-induced vasodilatation of internal carotid artery
Chaudhuri, A., Kanjwal, Y., Mohanty, P., Rao, S. G., Sung, B. H., Wilson, M. F., & Dandona, P. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90161-0 · Cited by 32
Ueda, S., Petrie, J. R., Cleland, S. J., Elliott, H. L., & Connell, J. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4897 · Cited by 33
Wiernsperger, N. F. (1994) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610100305 · Cited by 37
Lopes, H. F., & Egan, B. M. (2006) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2006001700022 · Cited by 56
Limberg, J. K., Soares, R. N., & Padilla, J. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01456-1 · Cited by 36
Chien, W., Yang, K., Eng, H.-L., Hu, Y.-H., Lee, P. Y., Wang, S., & Wang, P. W. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70168-4 · Cited by 30
“Finally, it has been proposed that insulin mediated vasodilation induced by NO release represents a physiological mechanism for postprandial glucose disposal [37-39].”
BackgroundInsulin-induced vasodilation is dependent on tetrahydrobiopterin synthesis
Verma, S., Arikawa, E., Yao, L., Laher, I., & McNeill, J. H. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90273-6 · Cited by 31
Muscle glycogen recovery after exercise during glucose and fructose intake monitored by13C-NMR
Van Den Bergh, A. J., Houtman, S., Heerschap, A., Rehrer, N. J., Van Den Boogert, H. J., Oeseburg, B., & Hopman, M. T. E. (1996) · Journal of Applied Physiology · doi:10.1152/jappl.1996.81.4.1495 · Cited by 30
Takagi, M., Tanaka, Y., Yamasaki, Y., Yamamoto, M., Hori, M., Nakaniwa, T., Niwa, M., Uchino, H., Tamura, Y., Nomiyama, T., et al. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00169.2002 · Cited by 30
“INFUSION OF INSULIN during hyperinsulinemic euglycemic glucose clamp studies can enhance sympathetic nerve activity (SNA), as detected by monitoring muscle microelectrodes, but this phenomenon is not observed when glucose or fructose is infused without insulin, suggesting an insulin-specific effect on SNA (20).”
BackgroundUtriainen, T., Mäkimattila, S., Virkamäki, A., Lindholm, H. J., Sovijärvi, A. R. A., & Yki-Järvinen, H. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954024 · Cited by 30
Contribution of blood flow to leg glucose uptake during a mixed meal
Hernandez Mijares, A., & Jensen, M. D. (1995) · Diabetes · doi:10.2337/diabetes.44.10.1165 · Cited by 29
Do the obese have lower body temperatures? A new look at a forgotten variable in energy balance.
Landsberg, L., Young, J. B., Leonard, W. R., Linsenmeier, R. A., & Turek, F. W. (2009) · PubMed · Cited by 48
Insulin stimulates epinephrine release under euglycemic conditions in humans
Tack, C. J., Lenders, J. W. M., Willemsen, J. J., van Druten, J. A. M., Thien, T., Lutterman, J. A., & Smits, P. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90251-7 · Cited by 29
Doiron, J. E., Li, Z., Yu, X., LaPenna, K. B., Quiriarte, H. D., Allerton, T. D., Koul, K., Malek, A. J., Shah, S. J., Sharp, T. E., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032646 · Cited by 26
“78 Hyperinsulinemia, obesity, and metabolic syndrome have all been shown to increase sympathetic activity independent of changes in BP. 79–81 A potential mechanism contributing to this effect is that sympathetic overactivation increases expression of SGLT2 (sodium/ glucose cotransporter 2) in the renal proximal tubule…”
BackgroundRegulation of microvascular flow and metabolism: An overview
Keske, M. A., Dwyer, R. M., Russell, R., Blackwood, S. J., Brown, A. A., Hu, D., Premilovac, D., Richards, S. M., & Rattigan, S. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12688 · Cited by 29
Postexercise repletion of muscle energy stores with fructose or glucose in mixed meals ,
Rosset, R., Lecoultre, V., Egli, L., Cros, J., Dokumacı, A. S., Zwygart, K., Boesch, C., Kreis, R., Schneiter, P., & Tappy, L. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.138214 · Cited by 28
Self-citationMultiple Cell Signalling Pathways of Human Proinsulin C-Peptide in Vasculopathy Protection
Souto, S. B., Campos, J. R. S., Fangueiro, J. F., Silva, A. M., Cicero, N., Lucarini, M., Durazzo, A., Santini, A., & Souto, E. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020645 · Cited by 27
“Enhanced renal sympathetic drive is a common feature in patients with various forms of hypertension and it is associated with components of the metabolic syndrome [123,131,132].”
BackgroundSpraul, M., Ravussin, É., & Baron, A. (1996) · Diabetologia · doi:10.1007/bf00400418 · Cited by 28
“The action of insulin on skeletal muscle blood flow and blood pressure regulation has recently attracted considerable interest [1-10].”
BackgroundResultInfluentialRegional Cerebral Activation Accompanies Sympathoexcitation in Women With Polycystic Ovary Syndrome
Lansdown, A., Warnert, E. A. H., Sverrisdóttir, Y. B., Wise, R. G., & Rees, A. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00065 · Cited by 27
“In 413 humans, hyperinsulinemia increases MSNA and modifies baroreflex control of sympathetic 414 activity [43-44] although these effects of insulin on sympathetic outflow may be blunted in 415”
BackgroundKobayashi, D., Takamura, M., Murai, H., Usui, S., Ikeda, T., Inomata, J.-I., Takashima, S., Kato, T., Furusho, H., Takeshita, Y., et al. (2010) · Autonomic Neuroscience · doi:10.1016/j.autneu.2010.05.003 · Cited by 24
“Several studies have shown that insulin augments sympathetic outflow to skeletalmuscle in humans (Anderson et al., 1991;Berne et al., 1992; Vollenweider et al., 1993).”
BackgroundBardgett, M. E., Sharpe, A. L., & Toney, G. M. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00291.2014 · Cited by 25
“Glucose infusions are known to increase muscle SNA in humans (38), and hyperinsulinemic euglycemic clamps in rodents have been reported to likewise increase lumbar SNA with little increase in renal SNA (3, 22, 40).”
BackgroundIs insulin the new intermittent hypoxia?
Limberg, J. K., Curry, T. B., Prabhakar, N. R., & Joyner, M. J. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.03.014 · Cited by 31
“rinsulinemic euglycemic clamp is both gradual [20,21,24,29], and sustained [30], such that MSNA remains increased even after plasma insulin levels return to baseline (See Fig.”
Blockade of Angiotensin II Receptors Inhibits the Increase in Blood Pressure Induced by Insulin
Nakata, T., Takeda, K., Hatta, T., Kiyama, M., Moriguchi, J., Miki, S., Kawa, T., Morimoto, S., Nakamura, K., Uchida, A., et al. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199802000-00010 · Cited by 24
Paolisso, G., Manzella, Rizzo, M. R., Barbieri, Gambardella, A., & Varricchio (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00626.x · Cited by 24
Monnard, C. R., & Grasser, E. K. (2018) · Advances in Nutrition · doi:10.1093/advances/nmx023 · Cited by 24
Sympathetic Pathophysiology in Hypertension Origins: The Path to Renal Denervation
Esler, M., Osborn, J. W., & Schlaich, M. P. (2024) · Hypertension · doi:10.1161/hypertensionaha.123.21715 · Cited by 30
Soares, R. N., Reimer, R. A., Alenezi, Z., Doyle–Baker, P. K., & Murias, J. M. (2017) · Diabetes and Vascular Disease Research · doi:10.1177/1479164117731481 · Cited by 26
Lu, H., Duanmu, Z., Scislo, T. J., & Dunbar, J. C. (1998) · Clinical and Experimental Hypertension · doi:10.3109/10641969809053213 · Cited by 21
Utriainen, T., Malmstr�m, R., M�kimattila, S., et al. (1995) · Diabetologia · doi:10.1007/s001250050319 · Cited by 22
Chen, W., Chang, Y., He, L., Jian, X., Li, L., Gao, L., Yang, Y., Zeng, M., Liu, H., Zhao, A. Z., et al. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000001087 · Cited by 25
Relationship between insulin's haemodynamic effects and insulin‐mediated glucose uptake
ter Maaten, J. C., Voorburg, de Vries, P. M., ter Wee, P. M., Donker, & Gans, R. O. B. (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00273.x · Cited by 24
Expanding the indication spectrum: renal denervation in diabetes
Mahfoud, F., Ewen, S., Ukena, C., Linz, D., Sobotka, P. A., Cremers, B., & Böhm, M. (2013) · EuroIntervention · doi:10.4244/eijv9sra20 · Cited by 19
A New Pyrroline Compound Selective for I1-Imidazoline Receptors Improves Metabolic Syndrome in Rats
Fellmann, L., Regnault, V., Greney, H., Gasparik, V., Muscat, A., Max, J., Gigou, L., Oréa, V., Chetrite, G. S., Pizard, A., et al. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.205328 · Cited by 22
“Several symptoms of the MetS, such as insulin resistance, obesity, hypertension, have been individually associated with sympathetic hyperactivity (de Champlain et al., 1976; Coote and Sato, 1977; Vollenweider et al., 1993; Morgan et al., 1995; Grassi et al., 1998; Rumantir et al., 1999; Grassi et al., 2007; Parati and…”
BackgroundRole of the carotid chemoreceptors in insulin-mediated sympathoexcitation in humans
Limberg, J. K., Johnson, B. D., Mozer, M. T., Holbein, W. W., Curry, T. B., Prabhakar, N. R., & Joyner, M. J. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00257.2019 · Cited by 21
Limberg, J. K., Smith, J. A. H., Soares, R. N., Harper, J. L., Houghton, K. N., Jacob, D. W., Mozer, M. T., Grunewald, Z. I., Johnson, B. D., Curry, T. B., et al. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00250.2020 · Cited by 22
Glucose Reduces the Effect of Water to Promote Orthostatic Tolerance
Lu, C., Li, M.-H., Ho, S., Lu, C.-L., Lin, J.-C., Lin, T., Tung, C., & Tseng, C. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.267 · Cited by 19
Weiss, M., Bouchoucha, S., Aiad, F., Ayme‐Dietrich, E., Dali‐Youcef, N., Bousquet, P., Greney, H., & Niederhoffer, N. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00021.2015 · Cited by 20
Role of the arterial baroreflex in the sympathetic response to hyperinsulinemia in adult humans
McMillan, N. J., Soares, R. N., Harper, J. L., Shariffi, B., Moreno‐Cabañas, A., Curry, T. B., Manrique‐Acevedo, C., Padilla, J., & Limberg, J. K. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00391.2021 · Cited by 20
Selective alpha1-adrenoceptor blockade prevents fructose-induced hypertension
Tran, L. T., MacLeod, K. M., & McNeill, J. H. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2031-5 · Cited by 18
Defects in insulin action in chronic heart failure
Doehner, W., Anker, S. D., & Coats, A. J. S. (2000) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00058.x · Cited by 21
Müller, C., Voirol, M.-J., Stefanoni, N., Surmely, J., Jéquier, E., Gaillard, R., & Tappy, L. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800441 · Cited by 16
Self-citationSeravalle, G., & Grassi, G. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-62491-9_5 · Cited by 30
Hyperinsulinemia blunts sympathetic vasoconstriction: a possible role of β-adrenergic activation
Limberg, J. K., Soares, R. N., Power, G. J., Harper, J. L., Smith, J. A. H., Shariffi, B., Jacob, D. W., Manrique‐Acevedo, C., & Padilla, J. (2021) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00018.2021 · Cited by 16
Skeletal Muscle Vascular Function: A Counterbalance of Insulin Action
Mahmoud, A. M., Brown, M. D., Phillips, S. A., & Haus, J. M. (2015) · Microcirculation · doi:10.1111/micc.12205 · Cited by 16
Petrova, M., Townsend, R. R., & Teff, K. L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1752 · Cited by 18
Mélançon, S., Bachelard, H., Badeau, M., Bourgoin, F., Pǐtre, M., Larivière, R., & Nadeau, A. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01002.2005 · Cited by 16
“The vasodilating action of insulin has been confirmed by us in conscious rats (35) and by others in humans over a range of physiological insulin concentrations and by using different techniques (1, 51, 52).”
MethodThe Role of Adenosine in Insulin-Induced Vasodilation
Abbink, E. J., Vervoort, G., Tack, C. J., Lutterman, J. A., Schaper, N. C., & Smits, P. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199909000-00009 · Cited by 16
Wong, F. S.-H., Logan, A. G., & Blendis, L. M. (1996) · Hepatology · doi:10.1002/hep.510230304 · Cited by 16
Soares, R. N., Colosio, A. L., Murias, J. M., & Pogliaghi, S. (2019) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2018-0866 · Cited by 18
Li, J., Li, X., Liu, E., Copeland, P. M., Freudenreich, O., GOFF, D. C., Henderson, D. C., Song, X., & Fan, X. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.01.034 · Cited by 17
“Resting energy expenditure (REE) is variable among individuals and is the largest component of energy expenditure, comprising 60-80% of non-activity total energy expenditure (Goran 2000).”
BackgroundInfluential
Metadata
- Authors
- Vollenweider, P., Tappy, L., Randin, D., Schneiter, P., Jéquier, E., Nicod, P., & Scherrer, U.
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- Venue
- Journal of Clinical Investigation
- Published
- 1993-07-01
- Volume
- 92
- Issue
- 1
- Pages
- 147-154
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC293552
- OpenAlex
- W2126021651
- Cited by
- 321
- References
- 55
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2022: 6 · 2021: 6 · 2020: 5 · 2019: 8 · 2018: 3 · 2017: 11 · 2016: 12 · 2015: 7 · 2014: 9 · 2013: 12 · 2012: 15
- FWCI
- 47.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (28668)
- Nestec
- Topics
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- hyperinsulinemia, euglycemic clamp, muscle sympathetic nerve activity, skeletal muscle blood flow, carbohydrate metabolism, fructose infusion, glucose infusion, insulin, vasodilation, carbohydrate oxidation, energy expenditure
- MeSH terms
- Adult, Blood Glucose, Calorimetry, Catecholamines, Energy Metabolism, Fructose, Humans, Insulin, Muscles, Potassium, Regional Blood Flow, Sympathetic Nervous System, Vascular Resistance, Carbohydrate Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.